COCRYSTAL PHARMA, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COCRYSTAL PHARMA, INC. stock issued during period, value, other for the quarter ending 2025-12-31 was $1.03M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, other for the quarter ending 2025-09-30 was $4.18M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, other for fiscal 2025 was $5.21M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, other for fiscal 2011 was $6.96K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.21M 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.18M 10-Q · filed 2025-11-14 | |
| 2011-12-31 | $6.96K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |